Investor alert: neogenomics, inc. investors with substantial losses have opportunity to lead the neogenomics class action lawsuit - neo

San diego--( business wire )-- robbins geller rudman & dowd llp announces that purchasers or acquirers of neogenomics, inc. (nasdaq: neo) securities between february 27, 2020 and april 26, 2022, inclusive (the “class period”) have until february 6, 2023 to seek appointment as lead plaintiff in the neogenomics class action lawsuit. captioned goldenberg v. neogenomics, inc., no. 22-cv-10314 (s.d.n.y.), the neogenomics class action lawsuit charges neogenomics and certain of its top executives with violations of the securities exchange act of 1934.
NEO Ratings Summary
NEO Quant Ranking